NPPA computed the Retail Price of Chlorhexidine gluconate solution IP equivalent to Chlorhexidine 1% w/w + Metronidazole Benzoate IP equivalent to Metronidazole 1% w/w + Lignocaine Hydrochloride IP 2% w/w Gel for M/s Stedman Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer)

Mar 07, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 04, 2025, issued the Computation of Retail Price of Chlorhexidine gluconate solution IP equivalent to Chlorhexidine 1% w/w + Metronidazole Benzoate IP equivalent to Metronidazole 1% w/w + Lignocaine Hydrochloride IP 2% w/w Gel for M/s Stedman Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer).

The following has been stated namely: -

• The Retail Price has been computed based on the data from July, 2024

• The Retail Price has been computed for Each Film Coated Tablet Containing Chlorhexidine gluconate solution IP equivalent to Chlorhexidine 1% w/w + Metronidazole Benzoate IP equivalent to Metronidazole 1% w/w + Lignocaine Hydrochloride IP 2% w/w Gel for M/s Stedman Pharmaceuticals Pvt. Ltd. (Manufacturer & Marketer)

• The Total MAT is 37,33,26,483

[Notification No. 19(4402)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT